David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
CALL
Vornado Realty Trust
VNO
$7.27B
| $2.95M | ﹤0.01% |
70,200
+40,200
| +134% | +$1.7M |
|
2277
CALL
CRISPR Therapeutics
CRSP
$5.73B
| $2.95M | ﹤0.01% |
74,900
+15,600
| +26% | +$737K |
|
|
JWN
2278
CALL
DELISTED
Nordstrom
JWN
| $2.94M | ﹤0.01% |
121,900
-3,500
| -3% | -$80.8K |
|
2279
iShares MSCI Mexico ETF
EWW
$1.8B
| $2.94M | ﹤0.01% |
62,817
+23,470
| +60% | +$1.21M |
|
2280
CALL
Markel Group
MKL
$22.5B
| $2.93M | ﹤0.01% |
1,700
+1,200
| +240% | +$1.99M |
|
2281
PUT
GXO Logistics
GXO
$5.5B
| $2.93M | ﹤0.01% |
67,400
| – | – |
|
2282
Vanguard Morningstar Value ETF
VTV
$194B
| $2.92M | ﹤0.01% |
+17,256
| New | +$3.03M |
|
2283
CALL
UBS Group
UBS
$167B
| $2.92M | ﹤0.01% |
96,300
| – | – |
|
2284
Definitive Healthcare
DH
$84.3M
| $2.92M | ﹤0.01% |
709,769
+161,599
| +29% | +$707K |
|
2285
Keurig Dr Pepper
KDP
$43.8B
| $2.92M | ﹤0.01% |
90,808
-590,797
| -87% | -$20M |
|
2286
CALL
Hertz
HTZ
$745M
| $2.91M | ﹤0.01% |
795,700
+153,100
| +24% | +$553K |
|
2287
CALL
The Mosaic Company
MOS
$7.68B
| $2.91M | ﹤0.01% |
118,300
-9,600
| -8% | -$251K |
|
|
CDMO
2288
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.9M | ﹤0.01% |
235,175
-430,331
| -65% | -$4.93M |
|
|
TIXT
2289
DELISTED
TELUS International
TIXT
| $2.9M | ﹤0.01% |
739,609
+580,726
| +366% | +$2.2M |
|
2290
VICI Properties
VICI
$28.6B
| $2.9M | ﹤0.01% |
99,249
-21,323
| -18% | -$674K |
|
2291
CALL
ScottsMiracle-Gro
SMG
$3.57B
| $2.9M | ﹤0.01% |
43,700
+2,200
| +5% | +$174K |
|
2292
CALL
Northern Oil and Gas
NOG
$2.77B
| $2.9M | ﹤0.01% |
78,000
-1,200
| -2% | -$47K |
|
2293
Tractor Supply
TSCO
$18.2B
| $2.9M | ﹤0.01% |
54,605
-84,375
| -61% | -$4.77M |
|
2294
LiveRamp
RAMP
$2.29B
| $2.89M | ﹤0.01% |
95,324
-17,259
| -15% | -$482K |
|
2295
iShares Core Dividend Growth ETF
DGRO
$43.8B
| $2.89M | ﹤0.01% |
+47,123
| New | +$2.97M |
|
2296
Vertex
VERX
$2.2B
| $2.89M | ﹤0.01% |
54,115
+11,966
| +28% | +$580K |
|
2297
Matthews International
MATW
$673M
| $2.89M | ﹤0.01% |
104,294
-12,000
| -10% | -$307K |
|
2298
Mercer International
MERC
$27.7M
| $2.88M | ﹤0.01% |
443,160
+285,045
| +180% | +$1.87M |
|
2299
Jones Lang LaSalle
JLL
$17.8B
| $2.88M | ﹤0.01% |
11,376
+7,799
| +218% | +$2.08M |
|
2300
CEVA Inc
CEVA
$778M
| $2.88M | ﹤0.01% |
91,136
-48,855
| -35% | -$1.36M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $7.08B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.